GJC-30554-59080
2 vaccinations
5 coded responses
9 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 802 / CO
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Dose 1 — Pfizer-BioNTech
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 2 — Pfizer-BioNTech
-
2021-03-03
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Poor · Site: Pain, Itching · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, ItchingFree text: Swollen lymph nodesMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, ItchingFree text: Swollen lymph nodeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-07
- 2021-03-08
- 2021-03-09
-
2021-03-10
Survey response — day 7, dose 2MedDRA: Painful respiration — Feeling: Poor · Site: Itching · Fever · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Stabbing pain when taking deep breathsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous, Anxiety, Hormone level abnormal — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Anxiety Hormonal imbalances MiscarriageMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 12 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | |
| 2 | 2021-03-03 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-03-03 | Unsuccessful |
Free text
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph nodes
Systemic reaction (other): Swollen lymph node
Release 5 — day 7, dose 2
Systemic reaction (other): Stabbing pain when taking deep breaths
Release 11 — 12 months, dose 2
Symptoms: Anxiety Hormonal imbalances Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Hormone level abnormal | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Painful respiration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release